Latest news with #Latinx
New York Times
18 hours ago
- Politics
- New York Times
‘African American' Is Awkward. It's Time to Use ‘Black.'
In this episode of 'The Opinions,' the linguist and Opinion writer John McWhorter and David Leonhardt, the editorial director of Opinion, debate the politics of how we talk about race and identity and discuss whether 'Latinx' is a thing. Below is a transcript of an episode of 'The Opinions.' We recommend listening to it in its original form for the full effect. You can do so using the player above or on the NYT Audio app, Apple, Spotify, Amazon Music, YouTube, iHeartRadio or wherever you get your podcasts. The transcript has been lightly edited for length and clarity. David Leonhardt: My colleague John McWhorter wrote a fascinating recent column arguing that it's time to retire the term 'African American' and return to using 'Black' loudly and proudly, as John put it. I kept thinking about that article after I read it because it reminded me of so many other debates we have about the politics of language, especially involving questions of identity. John, in addition to writing for Times Opinion, is an associate professor of linguistics at Columbia University, and he spent years mulling over many of these questions. So I asked him to come on the show this week and talk through a list of hot-button linguistic issues. John, welcome to The Opinions. John McWhorter: Happy to be here, David. Thank you. Leonhardt: You write so much about identity and language and politics. How did you get interested in that intersection? Want all of The Times? Subscribe.
Time Business News
5 days ago
- Health
- Time Business News
Breakthrough Innovations Transforming Lung Cancer Diagnosis and Treatment
Lung cancer is a type of cancer that begins in the lungs, often caused by smoking, exposure to pollutants, genetic factors or commercial threats. Lung cancer market is increasing due to growing global lung cancer rate, awareness and increase in screening programs, progress in clinical technologies (such as low -dosage CT scans and liquid biopsy) and increasing remedies and development of targeted remedies and immunotherapy. Additionally, better healthcare in aging population and emerging areas is promoting infrastructure and early detection and demand for effective treatment solutions. Key Growth Drivers and Opportunities Growing Global Lung Cancer Rate: Rising global lung cancer rate is a major driver of lung cancer market development, as it increases the demand for early identity, accurate diagnosis and effective treatment solutions. One of the major causes of cancer-related deaths worldwide with lung cancer, healthcare systems are making heavy investments in advanced screening tools such as low-dosage CT scans and biomarker-based diagnosis to enable the first diagnosis. At the same time, rising patient numbers are accelerating the development and adoption of innovative remedies including targeted drugs and immunotherapy. The burden of growing disease also attracts more research funds and industry investment, further fuel to market expansion. Challenges The lung cancer market faces several borders, including advanced diagnosis and high cost of targeted treatments, which can limit access to areas with especially low and moderate income. Delayed diagnosis also disrupts the results of treatment due to lack of awareness, limited screening programs and non-specific initial symptoms. Additionally, the challenge of complex regulatory routes, delayed stage patients, and the challenge of managing side effects from therapy disrupts the market growth despite technological progress. Innovation and Expansion EQUAL Study Launches High-Risk Group Lung Cancer Screening Trial In May 2025, Researchers at the Dana-Farber Cancer Institute have begun testing a new, in-house blood test in an effort to screen for lung cancer and identify those who are at a higher risk of developing the disease even if they have never used tobacco. Epidermal growth factor receptor (EGFR) gene mutations can be common in the Asian and Hispanic/Latinx populations, which is the subject of the EQUAL (EGFR ctDNA Quantitative Assessment for Lung Cancer screening in Asian and Latinx populations) study. Possessing this mutation increases the risk of lung cancer because EGFR type mutations are linked to the illness. Additionally, the number of cancer diagnoses among Asian or Hispanic/Latinx individuals is increasing at a faster rate. With India's First LungLife Screening Program to Fight Lung Cancer, Apollo Cancer Centre Sets the Standard In March 2025, India's first LungLife Screening Program for early lung cancer diagnosis has been introduced by Apollo Cancer Centres (ACCs), a pioneer in state-of-the-art cancer care. Lung cancer, which makes up 5.9% of all malignancies and 8.1% of cancer-related deaths in India, is the target of this ground-breaking project. Early identification increases the survival rate and improves treatment results (LINK). Low-dose computed tomography (LDCT) early screening can greatly increase survival chances and help with early diagnosis. However, almost 80% of high-risk patients have never spoken to their doctors about screening. To allow early detection and save lives, it is imperative to improve knowledge and communication regarding lung cancer screening, particularly among high-risk individuals. Inventive Sparks, Expanding Markets The key players operating the lung cancer market include AstraZeneca, Hoffman La Roche, Eli Lilly and Company, Pfizer Inc., Merck & Co., Amgen Inc., Novartis AG, Johnson & Johnson, Teva Pharmaceuticals Industries Ltd., Bristol-Myers Squibb Company. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS
Time Business News
6 days ago
- Health
- Time Business News
Cutting-Edge Technologies in Lung Cancer Testing
A lung cancer diagnostic test is a medical procedure that is used to detect the presence of cancer cells in the lungs. These tests include imaging techniques (such as X-ray and CT scan), tissue biopsy, spit cytology, and advanced methods such as liquid biopsy and molecular tests to identify the type and phase of cancer. The growth of lung cancer diagnostic test market is inspired by increasing demand for personalized treatment based on the government's initiative for cancer screening and genetic profiling. Key Growth Drivers and Opportunities Rising Demand for Personalized Treatment: Increasing demand for personal treatment is significantly increasing the development of lung cancer diagnostic test market, as it requires accurate and wide diagnostic equipment to identify specific genetic mutations, biomarkers and cancer sub-types. Personal remedies, such as targeted drugs and immunotherapy, have greatly rely on accurate clinical consequences for tailor treatment schemes for individual patients. This has increased adopting advanced clinical techniques such as liquid biopsy, next generation sequencing (NGS), and molecular testing. Since healthcare provider and patients want more effective, less aggressive and sewn treatment approaches, the demand for high-collective clinical trials continues to promote market expansion. Challenges Lung cancer diagnostic test market faces many borders that can obstruct its growth and access. High costs associated with advanced clinical technologies such as PET scans, liquid biopsy and next generation sequencing make them less cheap in countries with less and moderate income. Additionally, delayed diagnosis in delayed diagnosis due to limited infrastructure, lack of efficient health professionals, and lack of awareness in the reduction of available tests. In some clinical methods, false positive or negative can also cause incorrect diagnosis, affecting the consequences of treatment. Regulatory barriers and variability in testing accuracy further limited widely adopting innovative clinical equipment in clinical settings. Innovation and Expansion An Innovative Lung Cancer Screening Trial for High-Risk Individuals has been launched by the EQUAL Study In May 2025, Researchers at the Dana-Farber Cancer Institute have begun testing a new, in-house blood test in an effort to screen for lung cancer and identify those who are at a higher risk of developing the disease even if they have never used tobacco. As lung cancer is becoming more common in younger people and among Asian or Hispanic/Latinx people who have never used tobacco, the team, led by the principal investigator and thoracic oncologist, associate director of Dana-Farber's Cancer Care Equity Program, designed the study. Epidermal growth factor receptor (EGFR) gene mutations can be common in the Asian and Hispanic/Latinx populations, which is the subject of the EQUAL (EGFR ctDNA Quantitative Assessment for Lung Cancer screening in Asian and Latinx populations) study. Possessing this mutation increases the risk of lung cancer because EGFR type mutations are linked to the illness. Additionally, the number of cancer diagnoses among Asian or Hispanic/Latinx individuals is increasing at a faster rate. The LuNGS Alliance has launched a Free NGS Biomarker Screening Program for Lung Cancer In March 2025, For patients with lung cancer throughout India, the Cancer Research and Statistics Foundation (CRSF)-led LuNGS Alliance has announced free lung NGS biomarker testing. AstraZeneca, Pfizer, and Roche support this program, and 4baseCare is the official lab partner. The initiative's goal is to raise awareness of precision oncology as a crucial, easily accessible, and reasonably priced therapy option for lung cancer. 4baseCare's TARGT First Solid test provides a thorough examination of 72 frequently mutated genes, revealing actionable biomarkers that allow for individualized treatment regimens based on each patient's own genetic profile. The test finds mutations that match FDA and NCCN-approved medications, enabling oncologists to offer more individualized, potent treatments that can greatly enhance patient outcomes. Inventive Sparks, Expanding Markets The key players operating in the lung cancer diagnostic test market includes Abbott, Illumina, Inc., Thermo Fischer Scientific, QIAGEN, Quest Diagnostics Incorporated, NeoGenomics, NanoString, Myriad Genetics Inc., F. Hoffmann-La Roche Ltd, Danaher, Agilent Technologies, Inc., AstraZeneca, Sanofi, and Janssen Pharmaceuticals, Inc. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS
Hypebeast
6 days ago
- Entertainment
- Hypebeast
Art Basel Miami Beach Reveals 2025 Exhibitor Lineup
Summary Art fair season is just around the corner and as galleries around the world ready for this fall's Armory Show and Frieze Seoul,Art Baselis chiming in with the exhibitor lineup for its upcomingMiami Beach edition. Set to take place from December 5 through 7, 285 galleries hailing from 44 countries and territories will come together at the Miami Beach Convention Center for the 2025 iteration of Art Basel Miami Beach. Under the direction of Bridget Finn for the second year, the fair will spotlight 'the most urgent artistic currents shaping the American scene today,' with a sharpened focus on Latinx, Indigenous and diasporic practices. Over two-thirds of the featured galleries operate in the Americas. In addition to the usual roster of mega-galleries and blue-chip names, 2025 fair will welcome 41 first-time exhibitors, including El Apartamento, Crisis, Parallel and Pasto Galeria from Latin America. New York's downtown gallery scene is also stepping up its presence, with inaugural booths from YveYang,Margot Samel, Candice Madey andKate Werble Gallery. Akin to previous editions, the the fair will be organized across four key sectors: Galleries, Nova, Positions and Survey. While details for a 2025 Meridian section have yet to come, Art Basel states that details regarding additional sectors and programming will be announced in the coming months. The strength and caliber of this year's exhibitors reaffirms Art Basel Miami Beach's centrality within the global art ecosystem' Finn expressed in a recent statement. 'This edition reflects the vitality of artistic production across the Americas—which continues to shape contemporary art practice, patronage, and discourse worldwide—and the fair's role as a critical gateway for introducing pioneering international artists and perspectives to the American market. It is bold, rigorous and attuned to the moment.' The winter fair will also reveal the medalists of the inauguralArt Basel Awards. Launched in February, the initiatives aims to spotlight 'exceptional achievement' across various creative landscapes. The 36 gold medalists announced in may will vote amongst themselves to reveal this year's gold medalists on December 4. The 2025 edition of Art Basel Miami Beach will take place from December 5 to 7, with VIP Previews held on December 3 and 4. See the full list of exhibiting galleries below. GALLERIES1miramadrid / 2miraarchiv303 Gallery47 CanalA Gentil CariocaMiguel Abreu GalleryAcquavella GalleriesAfriart GalleryAlexandre GalleryAlisan Fine ArtsAlmeida & Dale Galeria de ArteAltman SiegelAmes YavuzGaleria Raquel ArnaudAlfonso ArtiacoBANKBarrovon BarthaGallery BatonNicelle Beauchene GalleryLivia BenavidesRuth Benzacar Galeria de ArteBerggruen GalleryBerry CampbellPeter Blum GalleryMarianne Boesky GalleryTanya Bonakdar GalleryBortolamiBradley ErtaskiranLuciana Brito GaleriaBroadwayBen Brown Fine ArtsMatthew BrownCanadaCardi GalleryCasa TriânguloDavid CastilloCayónCentral FineGaleria Pedro CeraChapter NYJames Cohan GalleryCommonwealth and CouncilGalleria ContinuaPaula Cooper GalleryCrèvecœurCristea Roberts GalleryGalerie Chantal CrouselThomas Dane GalleryDastan GalleryTibor de NagyMassimodecarloJeffrey DeitchDocumentAnat EbgiEdel AssantiAndrew Edlin GalleryEl Apartamentogalerie frank elbazDerek Eller GalleryThomas Erben GalleryLarkin ErdmannGalerie Cécile FakhouryDaniel Faria GalleryEric Firestone GalleryKonrad Fischer GaleriePeter Freeman, Friedman GalleryJames FuentesGagaGagosianGalateaGavlakGemini GhebalyGladstone GalleryGomide&CoGalería Elvira GonzálezGoodman GalleryMarian Goodman GalleryGrayAlexander Gray AssociatesGarth Greenan GalleryGalerie Karsten GreveHales GalleryHauser & WirthGalerie Max HetzlerHirschl & Adler ModernEdwynn Houk GalleryPippy Houldsworth GalleryXavier HufkensGallery HyundaiIngleby GalleryInstituto de visiónIsla FlotanteAlison JacquesCharlie James Galleryrodolphe janssenJenkins Johnson GalleryNina JohnsonJohyun GalleryGalerie JudinKalfayan GalleriesCasey KaplanJan KapsKarmaKasminkaufmann repettoSean KellyAnton Kern GalleryGalerie Peter KilchmannTina Kim GalleryMichael Kohn GalleryDavid Kordansky GalleryAndrew Kreps GallerykurimanzuttoPearl Lam GalleriesLeeahn GalleryLehmann MaupinGalerie LelongLévy Gorvy DayanJosh LilleyLisson GalleryLocks GalleryJane Lombard GalleryLuhring AugustineMagenta PlainsMai 36 GalerieMaisterravalbuenaMatthew Marks GalleryPhilip Martin GalleryMartos GalleryBarbara Mathes GalleryMayoralMazzoleniMiles McEnery GalleryAnthony MeierMendes Wood DMMennourMaruani MercierMignoniVictoria MiroMnuchin GalleryThe Modern Institutemoniquemelochemor charpentierEdward Tyler NahemHelly Nahmad GalleryNanzukaneugerriemschneiderNicodim GalleryNight GalleryCarolina NitschGalerie NordenhakeGallery Wendi NorrisGalerie Nathalie ObadiaOMRGalleria Lorcan O'Neill RomaOrtuzarRoslyn Oxley9 GalleryPace PrintsParagonParker GalleryParrasch Heijnen GalleryFranklin Parrasch GalleryPatronPerrotinPetzelPKM GalleryPolígrafa Obra GràficaProyectos MonclovaGaleria Marilia RazukAlmine RechRegen ProjectsRele GalleryRoberts ProjectsNara RoeslerThaddaeus RopacMeredith Rosen GalleryMichael Rosenfeld GalleryLia RummaRichard Saltoun GallerySCAI The BathhouseEsther SchipperSchoelkopf GalleryGalerie Thomas SchulteMarc Selwyn Fine ArtJack Shainman GallerySusan Sheehan GallerySicardi Ayers BacinoSies + HökeSikkema Malloy JenkinsJessica SilvermanBruce SilversteinSimões de AssisSkarstedtSMAC Art GalleryFredric Snitzer GallerySociétéSperone WestwaterSprüth MagersSTPILuisa StrinaGalería SurTimothy TaylorTemplonCristin Tierney GalleryTilton GalleryTornabuoni ArtLeon Tovar GalleryTravesía CuatroTwo PalmsUffner & LiuULAEVadehra Art GalleryVan de WegheVan Doren WaxterTim Van Laere GalleryNicola VassellVedovi GalleryVermelhoVielmetter Los AngelesGalleri Nicolai WallnerWentrupMichael Werner GalleryWhite CubeYares ArtDavid Zwirner NOVAGalería Isabel AninatEspacio ValverdeRebecca Camacho PresentsLuis De Jesus Los AngelesGypsum GalleryUnion PacificHeidiLohaus SominskyCandice MadeyMax Estrella Gallerymother's tankstation limitedNazarian/CurcioGalerie Alberta PanePequod UltravioletaPhillida ReidRolf ArtChris Sharp GallerySilverlensPark View / Paul SotoWelancora GalleryKate Werble GalleryW—galeríaYveYang POSITIONS56 HENRYGalerie AllenCarbon 12CrisisFranz KakaLodosLomexMadragoaProyecto NasalNicolettiPasto GaleríaGaleria Dawid RadziszewskiMargot SamelThetaVerveZielinsky SURVEYPiero Atchugarry GalleryJack BarrettCatharine Clark GalleryErin Cluley GalleryDavid Peter FrancisSebastian GladstonekóGaleria MapaGaleria Elvira MorenoPaci contemporaryParallel OaxacaPauline PavecDiane Rosenstein GalleryRyan LeeSapar ContemporaryThe PitVoloshyn GalleryWooson
Los Angeles Times
6 days ago
- Entertainment
- Los Angeles Times
‘A place to celebrate ourselves': A music festival in Riverside moves ahead despite ICE fears
Despite the continuous presence of U.S. Immigration and Customs Enforcement in cities around California, organizers in Riverside have decided to forge ahead with the third edition of the Mucho Gusto Music Festival, an event held in the downtown area that's billed as 'a celebration of music without borders.' The announcement comes as other events catering to Latinx audiences across Southern California have been forced to implement extra security measures because of potential ICE raids, or have been postponed altogether. Levitt LA, which organizes an annual summer concert series at the Levitt Pavilion in MacArthur Park, announced earlier this month that it was prepared to change venues if needed. Festival Chapín de Los Angeles, a popular two-day celebration of Guatemalan culture held in the Westlake neighborhood, has been postponed from late August to mid October. Authorities have arrested more than 2,700 individuals since the raids began in June, according to Homeland Security. Many of the immigration enforcement operations have been carried out in predominantly Latinx neighborhoods and cities. According to the U.S. Census Bureau, 54% of Riverside's population identifies as Hispanic or Latinx. 'It's important right now that we put our money within our local economy to support each other,' said Eduardo Valencia, Mucho Gusto's artistic director and one of the founders of the festival. 'We [needed] a place to celebrate ourselves … to be in a space that really celebrates the fact that we are [a diaspora of] people, that we are people from other countries who immigrated [to the U.S.],' he added. This year's all-ages festival will be headlined by two bands that blend cumbia rhythms with psychedelic melodies, Tropa Magica and Combo Chimbita, as well as jazz band Brainstory. Cosme Cordova, owner of art gallery Division 9 and co-organizer of the festival, said that he believes the ICE raids are bringing people together. 'People are gathering and becoming stronger and more educated about the laws and the rules,' he said. Mucho Gusto organizers are hiring private security and will have two officers on site to ensure a safe space for the community. '2025 is the year of arts and culture in Riverside,' Mayor Patricia Lock Dawson told The Times. 'Riverside loves its festivals; they represent the heart of our community, bring people together, and celebrate the cultures that make our city unique. Our focus is, and will always be, on ensuring that all public events in Riverside, including Mucho Gusto, are safe, welcoming, and inclusive for everyone.' In a Facebook post from June 12, the chief of police, Larry Gonzalez, said the department will not enforce immigration laws and is dedicated to 'protect the members of [the Riverside] community.' 'The trust we've built with our residents and businesses matters deeply to us, and we remain firmly committed to your safety and well-being,' he added.
